Literature DB >> 24452649

Evidence of specific cognitive deficits in patients with chronic low back pain under long-term substitution treatment of opioids.

Marcus Schiltenwolf, Michael Akbar, Andreas Hug, Ute Pfüller, Simone Gantz, Eva Neubauer, Herta Flor, Haili Wang1.   

Abstract

BACKGROUND: There is a growing number of patients worldwide being treated with long-term opioids for chronic non-cancer pain, although there is limited evidence for their effectiveness in improving pain and function. Opioid-use related adverse effects, especially in cognitive functioning in these patients, are rarely evaluated.
OBJECTIVES: The present study investigated the cognitive functions of patients with chronic back pain who underwent long-term opioid treatment in comparison with those patients without opioid usage and healthy controls. STUDY
DESIGN: A prospective, nonrandomized, cross-sectional study.
SETTING: Multidisciplinary pain management clinic, specialty referral center, University Hospital in Germany.
METHODS: In a prospective cross-sectional design, 37 patients with chronic back pain who underwent long-term opioid therapy (OP) were compared with 33 patients with chronic back pain without opioid therapy (NO) and 25 healthy controls (HC). Assessment of primary outcome included cognitive function such as information processing speed, choice reaction time, pattern recognition memory, and executive function. Other data included pain, back function, depression and anxiety, use of medication, and education status. The relationship between cognitive functions and anxiety/depression was analysed.
RESULTS: Both patient groups needed significantly longer time in information processing when compared to HC (Group 1: 41.87 ± 20.47 Group 2: 38.29 ± 19.99 Group 3: 30.25 ± 14.19). Additionally, OP patients had significantly reduced spatial memory capacity, flexibility for concept change, and impaired performance in working memory assessment compared to NO patients and HC. The impaired cognitive outcomes were significantly associated with pain intensity, depression scores, and medication use. LIMITATIONS: Limitations include small number of patients with heterogeneous opioid therapy and the nonrandomized observational nature of the study.
CONCLUSIONS: Our findings give a differential view into the cognitive changes from chronic back pain with and without long-term opioids treatment. Chronic back pain itself impairs some distinct cognitive functions. Long-term opioid therapy adds further cognitive impairment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24452649

Source DB:  PubMed          Journal:  Pain Physician        ISSN: 1533-3159            Impact factor:   4.965


  37 in total

1.  Sex-Specific Disruption of Distinct mPFC Inhibitory Neurons in Spared-Nerve Injury Model of Neuropathic Pain.

Authors:  Andrea F Jones; Patrick L Sheets
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

2.  The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review.

Authors:  Diana M Higgins; Aaron M Martin; Dewleen G Baker; Jennifer J Vasterling; Victoria Risbrough
Journal:  Clin J Pain       Date:  2018-03       Impact factor: 3.442

Review 3.  Drug interactions with dementia-related pathophysiological pathways worsen or prevent dementia.

Authors:  Romain Barus; Johana Béné; Julie Deguil; Sophie Gautier; Régis Bordet
Journal:  Br J Pharmacol       Date:  2019-03-31       Impact factor: 8.739

Review 4.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

5.  Decreased activation of cingulo-frontal-parietal cognitive/attention network during an attention-demanding task in patients with chronic low back pain.

Authors:  Cui Ping Mao; Qiu Li Zhang; Fa Xiu Bao; Xia Liao; Xiao Li Yang; Ming Zhang
Journal:  Neuroradiology       Date:  2014-07-02       Impact factor: 2.804

6.  Discrepancies in sleep diary and actigraphy assessments in adults with fibromyalgia: Associations with opioid dose and age.

Authors:  Ashley F Curtis; Mary Beth Miller; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  J Sleep Res       Date:  2018-07-31       Impact factor: 3.981

7.  An Exploratory Factor Analysis of a Brief Self-Report Scale to Detect Neurocognitive Impairment Among Participants Enrolled in Methadone Maintenance Therapy.

Authors:  Michael Copenhaver; Roman Shrestha; Jeffrey A Wickersham; Damian Weikum; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2016-01-13

Review 8.  Characterizing the Interrelationships of Prescription Opioid and Benzodiazepine Drugs With Worker Health and Workplace Hazards.

Authors:  Michele Kowalski-McGraw; Judith Green-McKenzie; Sudha P Pandalai; Paul A Schulte
Journal:  J Occup Environ Med       Date:  2017-11       Impact factor: 2.162

9.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

10.  Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data.

Authors:  Catherine E Myers; Jony Sheynin; Tarryn Balsdon; Andre Luzardo; Kevin D Beck; Lee Hogarth; Paul Haber; Ahmed A Moustafa
Journal:  Behav Brain Res       Date:  2015-09-14       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.